Literature DB >> 20728116

Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux.

David M Kitchens1, Anthony Herndon, David B Joseph.   

Abstract

PURPOSE: Treatment for vesicoureteral reflux remains controversial. Lacking an evidence-based treatment protocol, we offered the option of terminating prophylactic antibiotics in otherwise healthy patients with persistent vesicoureteral reflux at age 5 years or greater. We report outcomes with respect to the urinary tract infection incidence and to whether surgical intervention was eventually done.
MATERIALS AND METHODS: We obtained institutional review board approval to retrospectively review the records of all children with vesicoureteral reflux from December 1999 to February 2009. Of this group we selected children 5 years old or older who had been taken off prophylactic antibiotics. We assessed children with primary vesicoureteral reflux in detail.
RESULTS: The records of 1,217 that we reviewed showed that antibiotics were discontinued in 185 patients, including 160 girls (89%) and 25 boys (11%), at an average age of 6.2 years. Average followup was 2.0 years with recorded followup up to 8 years off prophylaxis. In 50 girls (91%) and 5 boys (9%), urinary tract infection developed after discontinuing prophylaxis. Correction was done in 57 patients, including open repair in 34 and endoscopic injection in 23. Two patients underwent intervention at parent request after an average of 0.7 years of uneventful observation. We identified no parameter predicting patients at risk for urinary tract infection.
CONCLUSIONS: Urinary tract infection develops in 29% of patients 5 years old or older with persistent vesicoureteral reflux within 2 years after the cessation of prophylaxis. Most of these cases are febrile. Discontinuing antibiotics is reasonable but a prospective, randomized, long-term, multi-institutional trial is required to determine whether this approach is beneficial.
Copyright © 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20728116     DOI: 10.1016/j.juro.2010.04.020

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  [Primary vesicoureteral reflux].

Authors:  R Stein; C Ziesel; P Rubenwolf; R Beetz
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

Review 2.  Antibiotic prophylaxis in pediatric urology: an update.

Authors:  Saul P Greenfield
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

3.  Observation of patients with vesicoureteral reflux off antibiotic prophylaxis: physician bias on patient selection and risk factors for recurrent febrile urinary tract infection.

Authors:  Beth A Drzewiecki; John C Thomas; John C Pope; Mark C Adams; John W Brock; Stacy T Tanaka
Journal:  J Urol       Date:  2012-08-17       Impact factor: 7.450

Review 4.  Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis.

Authors:  Hsin-Hsiao S Wang; Rasheed A Gbadegesin; John W Foreman; Shashi K Nagaraj; Delbert R Wigfall; John S Wiener; Jonathan C Routh
Journal:  J Urol       Date:  2014-09-06       Impact factor: 7.450

5.  Endoscopic bulking materials for the treatment of vesicoureteral reflux: a review of our 20 years of experience and review of the literature.

Authors:  Boris Chertin; Stanislav Kocherov; Leonid Chertin; Alaeddin Natsheh; Amicur Farkas; Ofer Z Shenfeld; Sarel Halachmi
Journal:  Adv Urol       Date:  2011-04-06

6.  Girls and renal scarring as risk factors for febrile urinary tract infection after stopping antibiotic prophylaxis in children with vesicoureteral reflux.

Authors:  Michiko Nakamura; Kimihiko Moriya; Masafumi Kon; Yoko Nishimura; Hiroki Chiba; Takeya Kitta; Nobuo Shinohara
Journal:  World J Urol       Date:  2021-01-03       Impact factor: 4.226

7.  Guidelines for the medical management of pediatric vesicoureteral reflux.

Authors:  Hideshi Miyakita; Yutaro Hayashi; Takahiko Mitsui; Manabu Okawada; Yoshiaki Kinoshita; Takahisa Kimata; Yasuhiro Koikawa; Kiyohide Sakai; Hiroyuki Satoh; Masatoshi Tokunaga; Yasuyuki Naitoh; Fumio Niimura; Hirofumi Matsuoka; Kentaro Mizuno; Kazunari Kaneko; Masayuki Kubota
Journal:  Int J Urol       Date:  2020-04-01       Impact factor: 3.369

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.